NPCE compared with AXGN: revenue, margins and what each company keeps, and the suppliers and customers both name

NPCENeuroPace Inc

Mkt capRevenueRevenue

AXGNAxogen, Inc.

Mkt capRevenueRevenue

Compare

NPCENeuroPace Inc

AXGNAxogen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NPCE 4

—DIXI Medical USAunlistedsupplier

GBCIGreatbatchsupplier

—Micro Systems Technologies Managementunlistedsupplier

—Rapport Therapeuticsunlistedcustomer

Shared 0

No shared counterparties.

Only AXGN 3

—Evergenunlistedsupplier

—University of Florida Research Foundation (UFRF)unlistedsupplier

—University of Texas at Austin (UTA)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NPCENeuroPace Inc

12.36· pre 12.38· delayed

Mkt cap$422.2MRevenue$23MQ2 FY26Revenue$96MFY25

AXGNAxogen, Inc.

49.83· pre 49.83· delayed

Pre-marketNov 3 '26delayed

Mkt cap$2.9BRevenue$76MQ3 FY26Revenue$225MFY25

Compare

Pre-marketNov 3 '26delayed

NPCENeuroPace Inc

AXGNAxogen, Inc.

12.36pre 12.38delayed

Price

49.83pre 49.83delayed

$422.2M

Mkt cap

$2.9B

Q2 FY26$23M

Revenue

$76MQ3 FY26

FY25$96M

Revenue

$225MFY25

NPCE12.36vsAXGN49.83Pre-marketNov 3 '26delayed